Global Biosimilars Market 2023: Monoclonal Antibodies Continue to Lead the Way –

DUBLIN-(BUSINESS WIRE)–The Global Biosimilars Market Report was added to supply.

Due to the COVID-19 pandemic, telehealth and teledetailing (also called remote detailing or webcalling) have been exposed, which allow the commercialization branch of biosimilar companies to have a wide range with less repetition.

Moreover, the fluidity of the labor market is another new dynamic allowing for a greater variety of models for building commercialization. Monoclonal antibodies represent the largest product type in the global biosimilars market, with demand expected to account for over 50% in 2023 and valued at US$17.2 billion.

This global market compendium from the publisher analyzes the biosimilars market at a high level by product type, therapeutic area, and geographic region. The market is studied for historical/current trends and future forecast in terms of USD value for 2019, 2023 and 2026.

Types of products

  • Monoclonal antibodies

  • Erythropoietin

  • G-CSF

  • Insulin

  • others

Therapeutic areas

  • Oncology

  • Autoimmune disorders

  • Blood diseases

  • Growth hormone deficiency

  • others

Geographical regions

  • Europe

  • North America

  • Asia-Pacific region

  • The rest of the world

This report provides estimates and forecasts for the global biosimilars market. The study also provides the key market developments and a list of the major players in this market that are cited.

Main topics covered:


  • Types of products

  • Therapeutic areas

  • Geographical regions


  • Market search by geographic region

  • Market search by product type

  • Market research by therapeutic area


  • Europe

  • Search the European market by geographic region

  • Search the European market by product type

  • Search the European market by therapeutic area

  • North America

  • North America market research by geographic region

  • Search the North American market by product type

  • North America Market Research by Therapeutic Area

  • Asia-Pacific region

  • Search the Asia-Pacific market by geographic region

  • Search the Asia-Pacific market by product type

  • Asia Pacific Market Research by Therapeutic Area

  • The rest of the world

  • Market search in the rest of the world by geographic region

  • Search the rest of the world market by product type

  • Rest of the world market research by therapeutic area


  • mAbs – All the rage in the new wave of Biosimilars

  • Expiration of patents on basic biologics leads to biosimilars

  • Role of biosimilars in continuous manufacturing (CM) development and innovation.

  • The availability of biosimilars can affect the prices of biologic drugs

  • The Asia-Pacific region is witnessing a boom in biosimilars



The mentioned companies

  • Amgen, Inc.

  • AXXO GmbH

  • Biocad

  • Biogen, Inc.

  • Bioton SA

  • CH Boehringer Sohn AG & Co., KG.

  • Coherus Biosciences

  • Creative Biomart, Inc.

  • Dong-A Social Group

  • Dr. Reddy’s Laboratories Ltd.

  • Eli Lilly and Company

  • Genor Biopharma Co., Ltd.

  • Hetero Drugs Limited

  • Insud Pharma SL

  • Intas Pharmaceuticals Ltd

  • Kashiv Biosciences LLC

  • LG Chem

  • Lupine Limited

  • Mabxience SA

  • Mylan, Inc

  • Nippon Kayaku Co., Ltd.

  • Pfizer, Inc.

  • Reliance Life Sciences Pvt., Ltd.

  • Sandoz International GmbH

  • Shanghai Henlius Biotech, Inc.

  • Stada Medicinal Products Ltd

  • Teva Pharmaceutical Industries Limited

  • Wockhardt Limited

For more information on this report, visit

About is the world’s leading source for international market research reports and market data. We bring you the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.

Leave a Comment

Your email address will not be published. Required fields are marked *